Proof-of-principle for immune control of global HIV-1 reactivation in vivo

Clinical Infectious Diseases

Volumn 61, Issue 1, 2015, Pages 120-128

  Smith, Nicola M G ^a   Mlcochova, Petra ^b   Watters, Sarah A ^b   Aasa Chapman, Marlene M I ^b   Rabin, Neil ^c   Moore, Sally ^c   Edwards, Simon G ^d   Garson, Jeremy A ^b   Grant, Paul R ^c   Ferns, R Bridget ^b   Kashuba, Angela ^e   Mayor, Neema P ^b,f   Schellekens, Jennifer ^b,f   Marsh, Steven G E ^b,f   McMichael, Andrew J ^a   Perelson, Alan S ^g   Pillay, Deenan ^b,h   Goonetilleke, Nilu ^a,i   Gupta, Ravindra K ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d CENTRAL AND NORTH WEST LONDON NHS FOUNDATION TRUST   (United Kingdom)

^e UNC Hamner Institute for Drug Safety Sciences   (United States)

^f ROYAL FREE HOSPITAL   (United Kingdom)

^g LOS ALAMOS NATIONAL LABORATORY   (United States)

^h UNIVERSITY OF KWAZULU NATAL   (South Africa)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

CD8; cure; elite control; HIV; myeloablation

Indexed keywords

CISPLATIN; CYTARABINE; CYTOKINE; ETOPOSIDE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHYLPREDNISOLONE; NEUTRALIZING ANTIBODY; TETRAMER; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; MYELOABLATIVE AGENT;

ADULT; AGED; ANTIBODY TITER; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MATHEMATICAL MODEL; MYELOMA; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STAINING; VIREMIA; VIRION; VIRUS LOAD; VIRUS REACTIVATION; ADVERSE EFFECTS; AUTOTRANSPLANTATION; BLOOD; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MIDDLE AGED; MONONUCLEAR CELL; MULTIPLE MYELOMA; PHYSIOLOGY; STEM CELL TRANSPLANTATION; T LYMPHOCYTE SUBPOPULATION; THEORETICAL MODEL; VIROLOGY; VIRUS ACTIVATION;

ANTIBODIES, NEUTRALIZING; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; ENZYME-LINKED IMMUNOSPOT ASSAY; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MELPHALAN; MIDDLE AGED; MODELS, THEORETICAL; MULTIPLE MYELOMA; MYELOABLATIVE AGONISTS; STEM CELL TRANSPLANTATION; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION, AUTOLOGOUS; VIRUS ACTIVATION;

EID: 84953849058     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ219     Document Type: Article

References (35)

1. Shan L, Deng K, Shroff NS, et al. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 2012; 36: 491-501.
2. Goujard C, Chaix ML, Lambotte O, et al. Spontaneous control of viral replication during primary HIV infection: when is "HIV controller" status established? Clin Infect Dis 2009; 49: 982-6.
3. Deeks SG, Walker BD. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 2007; 27: 406-16.
4. Migueles SA, Sabbaghian MS, Shupert WL, et al. HLA B∗5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A 2000; 97: 2709-14.
5. Emu B, Sinclair E, Hatano H, et al. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for longterm virus control. J Virol 2008; 82: 5398-407.
6. Kiepiela P, Leslie AJ, Honeyborne I, et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004; 432: 769-75.
7. Betts MR, Nason MC, West SM, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006; 107: 4781-9.
8. Lambotte O, Boufassa F, Madec Y, et al. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin Infect Dis 2005; 41: 1053-6.
9. Kelleher AD, Long C, Holmes EC, et al. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med 2001; 193: 375-86.
10. Goulder PJ, Phillips RE, Colbert RA, et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997; 3: 212-7.
11. Barouch DH, Kunstman J, Kuroda MJ, et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 2002; 415: 335-9.
12. Jin X, Bauer DE, Tuttleton SE, et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virusinfected macaques. J Exp Med 1999; 189: 991-8.
13. Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999; 283: 857-60.
14. Pandrea I, Gaufin T, Gautam R, et al. Functional cure of SIVagm infection in rhesus macaques results in complete recovery of CD4+ T cells and is reverted by CD8+ cell depletion. PLoS Pathog 2011; 7: e1002170.
15. Friedrich TC, Valentine LE, Yant LJ, et al. Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication. J Virol 2007; 81: 3465-76.
16. Krishnan S, Wilson EM, Sheikh V, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis 2014; 209: 931-9.
17. Hatano H, Yukl SA, Ferre AL, et al. Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. PLoS Pathog 2013; 9: e1003691.
18. Saez-Cirion A, Shin SY, Versmisse P, Barre-Sinoussi F, Pancino G. Ex vivo T cell-based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses. Nat Protoc 2010; 5: 1033-41.
19. Goonetilleke N, Moore S, Dally L, et al. Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA-and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes. J Virol 2006; 80: 4717-28.
20. Liu MK, Hawkins N, Ritchie AJ, et al. Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. J Clin Invest 2013; 123: 380-93.
21. Perelson AS, Ribeiro RM. Modeling the within-host dynamics of HIV infection. BMC Biol 2013; 11: 96.
22. Williams KM, Gress RE. Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation. Best Pract Res Clin Haematol 2008; 21: 579-96.
23. Ribeiro RM, Qin L, Chavez LL, Li D, Self SG, Perelson AS. Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection. J Virol 2010; 84: 6096-102.
24. Markowitz M, Louie M, Hurley A, et al. A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J Virol 2003; 77: 5037-8.
25. Perelson AS, Essunger P, Cao Y, et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997; 387: 188-91.
26. Simonelli C, Zanussi S, Pratesi C, et al. Immune recovery after autologous stem cell transplantation is not different for HIV-infected versus HIV-uninfected patients with relapsed or refractory lymphoma. Clin Infect Dis 2010; 50: 1672-9.
27. Richman DD, Wrin T, Little SJ, Petropoulos CJ. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci U S A 2003; 100: 4144-9.
28. Huang KH, Bonsall D, Katzourakis A, et al. B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection. Nat Commun 2010; 1: 102.
29. Salgado M, Swanson MD, Pohlmeyer CW, et al. HLA-B∗57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice. J Virol 2014; 88: 3340-52.
30. Hutter G, Zaia JA. Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years. Clin Exp Immunol 2011; 163: 284-95.
31. Picker LJ, Reed-Inderbitzin EF, Hagen SI, et al. IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates. J Clin Invest 2006; 116: 1514-24.
32. Wright JK, Naidoo VL, Brumme ZL, et al. Impact of HLA-B∗81-associated mutations in HIV-1 Gag on viral replication capacity. J Virol 2012; 86: 3193-9.
33. Li CR, Greenberg PD, Gilbert MJ, Goodrich JM, Riddell SR. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994; 83: 1971-9.
34. Rueff J, Medinger M, Heim D, Passweg J, Stern M. Lymphocyte subset recovery and outcome after autologous hematopoietic stem cell transplantation for plasma cell myeloma. Biol Blood Marrow Transplant 2014; 20: 896-9.
35. Deng K, Pertea M, Rongvaux A, et al. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations. Nature 2015; 517: 381-5.